Impact BioMedical, Inc. (IBO)
0.453
-0.03
(-5.62%)
USD |
NYAM |
Aug 24, 16:00
0.4596
+0.01
(+1.46%)
After-Hours: 20:00
Impact BioMedical Total Assets (Quarterly) : 16.74M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.74M |
| March 31, 2026 | 17.09M |
| December 31, 2025 | 22.84M |
| September 30, 2025 | 18.21M |
| June 30, 2025 | 19.06M |
| March 31, 2025 | 20.05M |
| December 31, 2024 | 20.29M |
| September 30, 2024 | 46.70M |
| June 30, 2024 | 44.12M |
| March 31, 2024 | 44.36M |
| December 31, 2023 | 44.63M |
| September 30, 2023 | 45.08M |
| Date | Value |
|---|---|
| June 30, 2023 | 45.99M |
| March 31, 2023 | 46.30M |
| December 31, 2022 | 46.50M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 56.42M |
| September 30, 2021 | |
| June 30, 2021 | 53.81M |
| March 31, 2021 | |
| December 31, 2020 | 48.09M |
| September 30, 2020 | 0.1074M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | 8.944M |
| LENZ Therapeutics, Inc. | 236.60M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.733M |
| Shareholders Equity (Quarterly) | 10.77M |
| Current Ratio | 0.1565 |
| Net Debt Paydown Yield | 3.69% |